02:25 PM EDT, 03/16/2026 (MT Newswires) -- Health care stocks advanced Monday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding 0.9%.

The iShares Biotechnology ETF (IBB) gained 1.1%.

In corporate news, Fennec Pharmaceuticals ( FENC ) shares climbed past 4% after the company said it reached a settlement with Cipla Limited and Cipla USA, resolving patent litigation related to a proposed generic version of its Pedmark therapy.

Caris Life Sciences ( CAI ) gained 3.9% after it said Monday it has launched an AI tool designed to help doctors predict whether patients with high-grade serous ovarian cancer will become resistant to platinum-based chemotherapy.

CytomX Therapeutics ( CTMX ) shares surged 61% after it said a phase 1 clinical trial evaluating varsetatug masetecan in patients with advanced colorectal cancer yielded confirmed response rates of up to 32%.